Who is sponsoring NCT03279861?

NCT03279861 is sponsored by University of Maryland, Baltimore.

What condition does NCT03279861 study?

NCT03279861 studies Congestive Heart Failure, Hypertension.

What drugs are being tested in NCT03279861?

Interventions: Entresto, Valsartan.

What is the status of NCT03279861?

NCT03279861 is currently WITHDRAWN.

Last reviewed 2023-05-04 · How we verify

Sacubitril-valsartan (Entresto) Versus Standard Anti-hypertensive Therapy in LVAD Patients - A Feasibility Pilot Study

NCT03279861 Phase 4 WITHDRAWN

This pilot, feasibility study evaluates the efficacy of sacubitril-valsartan (Entresto) versus usual anti-hypertensive medications in patients with left ventricular assist devices (LVAD). It also measures diurnal blood pressure variations in the context of continuous flow physiology.

Details

Lead sponsor	University of Maryland, Baltimore
Phase	Phase 4
Status	WITHDRAWN
Start date	2017-11
Completion	2019-11

Conditions

Congestive Heart Failure
Hypertension

Interventions

Entresto
Valsartan

Primary outcomes

Time spent with MAP < 85 mmHg — 2 months
Daily mean arterial pressure (MAP) \< 85 mmHg